Survival and quality of life in the randomized, multicenter GLARIUS trial investigating bevacizumab/irinotecan versus standard temozolornide in newly diagnosed, MGMT-non-methylated glioblastoma patients

Herrlinger, Ulrich and Schaefer, Nildas and Steinbach, Joachim Peter and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Rohde, Veit and Ringel, Florian and Braun, Christian and Kohnen, Ralf and Leutgeb, Barbara and Belka, Claus and Urbach, Horst and Stummer, Walter and Gies, Martin (2014) Survival and quality of life in the randomized, multicenter GLARIUS trial investigating bevacizumab/irinotecan versus standard temozolornide in newly diagnosed, MGMT-non-methylated glioblastoma patients. JOURNAL OF CLINICAL ONCOLOGY, 32 (15supp): 2042. ISSN 0732-183X, 1527-7755

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurologie
Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT)
Depositing User: Petra Gürster
Date Deposited: 24 Jul 2020 08:56
Last Modified: 24 Jul 2020 08:56
URI: https://pred.uni-regensburg.de/id/eprint/10171

Actions (login required)

View Item View Item